Skip to main content
Log in

Effects of rifampicin on hepatic antioxidant enzymes in PXR and CAR double humanized mice

  • Original Article
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Background

Nuclear receptor are major regulators of hepatic drug metabolizing enzymes and antioxidants enzymes. Nuclear receptor humanized mice were used for overcome species differences between experimental animals and human.

Objective

The present study was performed to investigate the hepatic regulation of antioxidant enzymes in pregnane X receptor (PXR) and constitutive androstane receptor (CAR) double humanized mice treated with the human PXR ligand, rifampicin (RIF; 10 mg/kg for 4 days).

Results

RIF decreased the hepatic protein levels of superoxide dismutase-1, thioredoxin-1, and γ-glutamylcysteine ligase catalytic subunit in wild-type (WT) mice, but not in the double humanized mice. Catalase protein levels were decreased by RIF in both WT and double humanized mice. The hepatic protein level and activity of glutathione reductase (GR) were increased in the humanized mice treated with RIF, but decreased in WT mice. Glutathione S-transferase (GST) alpha-class (GSTA) and mu-class (GSTM) but not pi-class were induced by RIF in the humanized mice, but not in WT mice. The activities of total GST, GSTA and GSTM were also increased only in humanized mice treated with RIF.

Conclusion

These results suggest that PXR and CAR may play roles in xenobiotic-induced hepatic regulation of GSTA, GSTM, and GR. The PXR/CAR double humanized mouse can be used as a suitable predictive model of the regulation of human antioxidant enzymes by xenobiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Download references

Acknowledgements

This research was supported by a National Research Foundation of Korea Grant funded by the Korean Government (2018M3A9H1021640 and 2021R1A2C2004696) and Korea Institute of Science and Technology Europe basic research program (Project no. 12001).

Author information

Authors and Affiliations

Authors

Contributions

YJC, CSR, SYL, SJO and SKK conceptualized and design experiments. YJC, CSR, SYL, HGK, NYK, JYL, HJP, SWC, JHK performed the experiments and analyzed data. YJC, CSR, SYL and SKK wrote the paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sang Kyum Kim.

Ethics declarations

Conflict of interest

Young Jae Choi has declared that no competing interests exist. Chang Seon Ryu has declared that no competing interests exist. Sang Yoon Lee has declared that no competing interests exist. Ha Gyeong Kim has declared that no competing interests exist. Nan Young Kim has declared that no competing interests exist. Ji-Yoon Lee has declared that no competing interests exist. Soo Jin Oh has declared that no competing interests exist. Han-Jin Park has declared that no competing interests exist. Seung-Woo Cho has declared that no competing interests exist. Jong-Hoon Kim has declared that no competing interests exist. Sang Kyum Kim has declared that no competing interests exist.

Ethical approval

All experimental protocols and procedures were approved and conducted according to the approved guidelines and regulations of the Institutional Animal Care and Use Committee (IACUC) of the Korea Research Institute of Bioscience and Biotechnology (KRIBB).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, Y.J., Ryu, C.S., Lee, S.Y. et al. Effects of rifampicin on hepatic antioxidant enzymes in PXR and CAR double humanized mice. Mol. Cell. Toxicol. 17, 277–286 (2021). https://doi.org/10.1007/s13273-021-00134-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13273-021-00134-9

Keywords

Navigation